VIVUS (VVUS) News Today → Putin and other countries have a plan (From Whats On Finance) (Ad) Free VVUS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVIVUS Provides Update on Pipeline and Program Milestonesmarkets.businessinsider.com - January 8 at 10:04 AMMetaview announces Answers, the world's first conversational AI for the interview processit.tmcnet.com - May 25 at 11:10 AMWhy aren’t new drugs that can help you lose weight more widely used? - MarketWatchmarketwatch.com - October 2 at 3:59 PM'There's no way that patients are going to be able to afford that.' Why aren't new drugs that can help you lose weight more widely used? - Morningstarmorningstar.com - October 2 at 10:58 AMErectile Dysfunction Drugs Market to Surpass Around USD 4079.9 Million by 2028, Says Brandessence Market Research - Yahoo Financefinance.yahoo.com - September 23 at 10:29 AMForm DEF 14A Catalent, Inc. For: Oct 27 - StreetInsider.comstreetinsider.com - September 16 at 11:39 AMObesity Management Market Expanding at an Impressive CAGR - GlobeNewswireglobenewswire.com - September 9 at 6:33 AMGlobal Human Reproductive Technology Products and Markets Analysis Report 2022: Data from 2020-2021, Estimates for 2022, and CAGR Projections through 2027 - Yahoo Financefinance.yahoo.com - August 26 at 5:01 PMGlobal Human Reproductive Technology Products and Markets Analysis Report 2022: Data from 2020-2021, Estimates for 2022, and CAGR Projections through 2027 - PR Newswireprnewswire.com - August 26 at 11:57 AM2022-08-15 | NDAQ:PTPI | Press Release | Petros Pharmaceuticals Inc. - Stockhousestockhouse.com - August 17 at 1:08 AMPetros Pharmaceuticals Reports Record Revenue and Gross Profit During Second Quarter 2022 - StreetInsider.comstreetinsider.com - August 15 at 8:44 AMKaléo Announces Executive Appointments and New Government Business Unit - Yahoo Financefinance.yahoo.com - August 11 at 6:08 PMIcahn Enterprises L P : Reports Second Quarter 2022 Financial Results - Form 8-K - Marketscreener.commarketscreener.com - August 5 at 3:35 AMGlobal Cystic Fibrosis Market Report 2022-2030: CFTR Modulators Segment to Dominate the Market - Benzingabenzinga.com - August 2 at 2:24 PMGlobal Cystic Fibrosis Market Report 2022: Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts 2020-2030 - ResearchAndMarkets.com - Business Wirebusinesswire.com - July 31 at 8:43 PMGlobal Achondroplasia Market to Surpass US$ 1100.97 Million by 2030, Says Coherent Market Insights (CMI) - GlobeNewswireglobenewswire.com - July 26 at 9:47 AMThe best stock investing strategy for 2022: Don’t buy the dip, buy the dividend - Fortunefortune.com - July 14 at 9:41 AMBioXcel Therapeutics Appoints Michael P. Miller to Board of Directors - Yahoo Financefinance.yahoo.com - July 5 at 11:46 PMBioXcel Therapeutics Appoints Michael P. Miller to Board of Directors - StreetInsider.comstreetinsider.com - July 5 at 6:45 PMOverweight Treatment Market estimated to surge ahead at a CAGR of 7.9% by the end of 2032 - Persistence M - Benzingabenzinga.com - June 8 at 7:00 PM2022-05-16 | NDAQ:PTPI | Press Release | Petros Pharmaceuticals Inc. - Stockhousestockhouse.com - May 16 at 6:00 PMIcahn Enterprises (IEP) Q1 2022 Earnings Call Transcript - The Motley Foolfool.com - May 6 at 1:05 PMPetros Pharmaceuticals to Pursue 505(B)(2) Pathway for H-100, Company's Novel Topical Investigational Treatment for Peyronie's Disease Which Impacts More Than 1 in 10 Men in the US - GuruFocus.comgurufocus.com - May 3 at 6:09 PMPetros Pharmaceuticals to Pursue 505(B)(2) Pathway for H-100, Company's Novel Topical Investigational Treatment for Peyronie's Disease Which Impacts More Than 1 in 10 Men in the US - GlobeNewswireglobenewswire.com - May 3 at 1:09 PMPetros Pharmaceuticals, Inc. Engages Massachusetts General Hospital in a Sponsored Research Agreement for Tissue-Specific Oxygenation Sensor Technology - GuruFocus.comgurufocus.com - April 27 at 7:58 PMPetros Pharmaceuticals, Inc. Engages Massachusetts General Hospital in a Sponsored Research Agreement for Tissue-Specific Oxygenation Sensor Technology - Yahoo Financefinance.yahoo.com - April 26 at 2:52 PMPetros Pharmaceuticals Announces Positive Results of Over-the-Counter (OTC) Label Comprehension Study for Erectile Dysfunction Drug STENDRA (avanafil) - GlobeNewswireglobenewswire.com - April 19 at 9:21 AMDiet Pills Market Size Worth $2.27Bn, Globally, by 2028 at 10.4% CAGR - Exclusive Report by The Insight Partners - PR Newswireprnewswire.com - April 5 at 11:24 AMGlobal Obesity Treatment Market Research Report to 2027 - Emerging Demand for Minimally Invasive Methods Presents Opportunities - ResearchAndMarkets.com - Business Wirebusinesswire.com - April 1 at 10:35 AMPETROS PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - Marketscreener.commarketscreener.com - March 31 at 7:11 PMPhosphodiesterase Inhibitors Market: Industry Analysis and Opportunity Assessment 2028 - Benzinga - Benzingabenzinga.com - March 30 at 7:41 AMErectile Dysfunction (ED) Drugs Market: 4.76% YOY Growth Rate in 2022 | By Product (oral drugs, topical drugs, and others) and Geography | Growth, Trends, and Forecasts (2022 - 2026) - PR Newswireprnewswire.com - March 23 at 9:11 PMDrugs For Erectile Dysfunction Global Market Report 2022 - Yahoo Financefinance.yahoo.com - March 16 at 5:59 PMEquillium : Announces Appointment of Barbara Troupin to Board of Directors - Form 8-K - Marketscreener.commarketscreener.com - March 3 at 8:51 PMWhy Zscaler Stock Plunged Today - Nasdaqnasdaq.com - February 26 at 4:29 AMIcahn Enterprises (IEP) Q4 2021 Earnings Call Transcript - The Motley Foolfool.com - February 25 at 6:20 PMIcahn Enterprises L.P. (IEP) CEO David Willetts on Q4 2021 Results - Earnings Call Transcript - Seeking Alphaseekingalpha.com - February 25 at 1:15 PMErectile Dysfunction Drugs Market size worth $ 2952 Million, Globally, by 2028 at -3.4% CAGR: Verified Market Research® - Yahoo Financefinance.yahoo.com - February 11 at 9:18 AMPETROS PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement (form 8-K) - marketscreener.commarketscreener.com - January 21 at 6:59 PMPetros Pharmaceuticals Launches Two Self-Selection Studies for Erectile Dysfunction Drug STENDRA® (avanafil) - PRNewswireprnewswire.com - January 19 at 10:57 AMAytu BioPharma Appoints Mark Oki as Chief Financial Officer - StreetInsider.comstreetinsider.com - January 4 at 8:43 AMForm 424B3 Petros Pharmaceuticals, - StreetInsider.comstreetinsider.com - December 20 at 1:54 PMPetros Pharmaceuticals Announces Positive Over-the-Counter (OTC) Label Comprehension Study Results for Erectile Dysfunction Drug STENDRA® (avanafil) - PRNewswireprnewswire.com - December 10 at 2:57 AMForm 424B5 Petros Pharmaceuticals, - StreetInsider.comstreetinsider.com - December 2 at 12:19 AMPetros Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update - PRNewswireprnewswire.com - November 15 at 6:26 PMAnnouncement of Retirement of Judge Christopher Sontchi - marketscreener.commarketscreener.com - November 15 at 1:24 PMPetros Pharmaceuticals Expands Program for Novel Investigational Non-Invasive Treatment Formulation for Peyronie's Disease - PRNewswireprnewswire.com - November 9 at 9:21 AMObesity Treatment Market Research Report by Drugs, by Surgery & Devices, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19 - Yahoo Financefinance.yahoo.com - November 8 at 12:56 PMEsperion Announces the Appointment of Seth HZ Fischer to its Board of Directors - StreetInsider.comstreetinsider.com - November 3 at 9:13 AMIcahn Enterprises (IEP) Q3 2021 Earnings Call Transcript - Motley Foolfool.com - November 3 at 4:13 AM Get VIVUS News Delivered to You Automatically Sign up to receive the latest news and ratings for VVUS and its competitors with MarketBeat's FREE daily newsletter. Email Address He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here VVUS Media Mentions By Week VVUS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VVUS News Sentiment▼0.000.46▲Average Medical News Sentiment VVUS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VVUS Articles This Week▼00▲VVUS Articles Average Week Get VIVUS News Delivered to You Automatically Sign up to receive the latest news and ratings for VVUS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cumberland Pharmaceuticals News Today eFFECTOR Therapeutics News Today Chemomab Therapeutics News Today Can-Fite BioPharma News Today Trevena News Today Pasithea Therapeutics News Today Tenax Therapeutics News Today Pulmatrix News Today Lixte Biotechnology News Today Universe Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VVUS) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VIVUS, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
